Search Results - "Deshpande, L.M."

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci by Deshpande, L.M., Jones, R.N.

“…BAL9141 has been reported to have inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA), many enterococci, and streptococci with…”
Get full text

blaVIM₋₂ and blaVIM₋₇ Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program by Aboufaycal, H, Sader, H.S, Rolston, K, Deshpande, L.M, Toleman, M, Bodey, G, Raad, I, Jones, R.N

“…Two Pseudomonas aeruginosa strains resistant to beta-lactams, fluoroquinolones, aminoglycosides, tetracyclines, and carbapenems and susceptible only to…”
Get full text

Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods by Deshpande, L.M., Fix, A.M., Pfaller, M.A., Jones, R.N.

“…Staphylococci cause one-third of all serious invasive infections in the SENTRY Antimicrobial Surveillance Program including bacteremias and lower respiratory…”
Get full text

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999) by Deshpande, L.M., Jones, R.N.

“…In vitro activity of four newer fluoroquinolones (clinafloxacin, gemifloxacin, moxifloxacin, sitafloxacin) and an equal number control drugs in the same class…”
Get full text

GAR-936 (9- t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria by Deshpande, L.M, Gales, A.C, Jones, R.N

“…GAR-936, a new semisynthetic derivative of minocycline, has earlier shown promising activity against tetracycline-resistant pathogens, including Streptococcus…”
Get full text

AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains by Jones, R.N., Anderegg, T.R., Deshpande, L.M.

“…AZD2563, a novel oxazolidinone, was tested against 10 well characterized multiple-resistant strains of staphylococci and viridans group or β-hemolytic…”
Get full text

Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae by Deshpande, L.M., Beach, M.L., Mutnick, A. H, Jones, R.N.

“…A new orally administered cephalosporin, LB10827, was compared to 16 other antimicrobial agents tested against Streptococcus pneumoniae (520 strains),…”
Get full text